FLFlávia Mauad Levy

Flávia Mauad Levy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Flávia Mauad Levy has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synergistic effect of Maquiberry cystatin, sodium fluoride and stannous chloride for the prevention of initial dental erosion in vitro

    by Vinícius Taioqui Pelá, Thelma Lopes Silva, Even Akemi Taira, Geórgia Almeida Sant’aNa, Letícia Oba Sakae, Flávia Mauad Levy, Taís Scaramucci Forlin, Eduardo Pereira de Souza, Talita Mendes Oliveira Ventura, Thiago Saads Carvalho, et al.

    Objective This study analyzed the synergistic effect between a recombinant Maquiberry (MaquiCPI-3) protein, sodium fluoride (NaF), and stannous chloride (SnCl2) against initial dental erosion in vitro.


  • Open Access

    “RichBlend” protocol for full-face filling and collagen biostimulation

    by Elizandra Paccola Moretto de Almeida, Flávia Mauad Levy, Marília Afonso Rabelo Buzalaf

    The “RichBlend” protocol was designed for facial filling and collagen biostimulation, by means of a mixture of calcium hydroxyapatite (CaHA), hyaluronic acid (AH) and autologous platelet concentrates. This work reports the case of a 53-year-old patient with cutaneous photoaging, loss of facial volume, multiple rhythms in the frontal and periorbital regions, also marked skin flaccidity, especially the eyelid. The treatment was done with botulinum toxin (65 U) and the “RichBlend” protocol. Venipuncture was performed and the blood was centrifuged to obtain i-PRF (injectable platelet-rich fibrin) and plasma gel. After venipuncture and blood centrifugation, i-PRF and plasma gel were obtained. CaHA (Radiesse®) was diluted: a) in saline solution + i-PRF (hyperdilution) for biostimulationof the lower third of the face; and b) in AH (Juvederm Ultraplus XC®) + plasma gel, for hydrolifting on the forehead and dark circles, malar and temples. Plasma gel was applied to the nasogenian grooves and then the entire face was properly massaged. The “RichBlend” protocol rejuvenated the patient, as it promoted filling, volumizing, collagen formation (biostimulation), reduction of flaccidity, in addition to skin whitening. Since HA and CaHA are high-cost products, their mixture with autologous platelet concentrates, in liquid or gel form, allows the use of a greater amount of filled and biostimulator material on the face, at a more affordable cost.


  • Top Cited Papers
    Open Access

    Autologous platelet concentrates for facial rejuvenation

    by Marília Afonso Rabelo Buzalaf, Flávia Mauad Levy

    MEDLINE (PubMed) was searched from inception through 2021 for English language publications on APCs for facial rejuvenation. A total of 100 files were found. Based on the available literature, APCs for skin rejuvenation are safe and well tolerated. The most studied product is the first-generation material, platelet-rich plasma (PRP). The results are in general favorable, but the quality of the studies is low. The second and third generation products, platelet-rich fibrin (PRF) and injectable platelet-rich fibrin (i-PRF), respectively, are easier to be obtained and, at least in vitro , seem to induce greater collagen production than PRP, especially under lower relative centrifugation forces, but to date only a few clinical trials evaluating these products exist. More high-quality trials with appropriate follow-up are necessary to provide adequate evidence that may help to improve the treatment regimens with APCs. Many aspects should be considered when designing clinical trials to evaluate APCs, such as the patients’ characteristics that best predict a favorable response, the optimal number of sessions and the interval between them, the characteristics of the studies and the development of better instruments to evaluate skin aging.


  • Open Access

    Characterization of white spot lesions formed on human enamel under microcosm biofilm for different experimental periods

    by Flávia Mauad Levy, Aline Silva Braga, Vinícius Taioqui Pelá, Stacey Lavender, Dennis Zhang, Shira Pilch, Zilson Malheiros, Bernal Stewart, Ana Carolina Magalhães, Marília Afonso Rabelo Buzalaf

    This study characterized artificial white spot lesions produced on human enamel under microcosm biofilm for different experimental periods. In total, 100 human enamel specimens (4x4mm) were assigned to 5 distinct groups (n=20/group) differing according to the period of biofilm formation (2, 4, 6, 8 or 10 days). Microcosm biofilm was produced on the specimens from a mixture of human and McBain saliva at the first 8h. Enamel samples were then exposed to McBain saliva containing 0.2% sucrose. WSLs formed were characterized by quantitative light-induced fluorescence (QLF) and transverse microradiography (TMR). Data were analyzed by ANOVA/Tukey or Kruskal-Wallis/Dunn tests (pa, -8.52(-8.75:-8.00)ab, -9.17(-10.00:-8.71)bc, -9.58(-10.53:-8.99)bc and -10.01(-11.44:-9.72)c for 2, 4, 6, 8, and 10 days, respectively. For TMR, median (95%CI; vol%.µm) ∆Z were 1410(1299-1479)a, 2420(2327-2604)ab, 2775(2573-2899)bc, 3305(3192-3406)cd and 4330(3972-4465)d, whereas mean (SD; µm) lesion depth were 53.7(12.3)a, 71.4(12.0)a, 103.8(24.8)b, 130.5(27.2)bc, 167.2(39.3)c for 2, 4, 6, 8 and 10 days, respectively. The progression of WSLs formed on human enamel under microcosm biofilm can be characterized over 2-10 days, both by QLF and TMR analyses, although the latter provides better discrimination among the lesions.


  • Open Access

    Do commercial whitening dentifrices increase enamel erosive tooth wear?

    by Ana Clara Correa Duarte Simões, Aline Dionizio, João Victor Frazão Câmara, Isabela Tomazini Sabino-Arias, Flávia Mauad Levy, Talita Mendes Oliveira Ventura, Nathalia Rabelo Buzalaf, Thiago Beltrami Dias Batista, Ana Carolina Magalhães, Sonia Groisman, et al.

    This in vitro study evaluated the effect of commercial whitening dentifrices on erosive tooth wear (ETW) of bovine enamel samples, in comparison with commercial regular dentifrices. Sixty bovine crowns were embedded in acrylic resin, polished and then had their baseline profile determined. They were randomly assigned to 5 groups (n=12/group), according to the type of commercial dentifrice to be tested: GI - Crest Anti-cavity Regular; GII - Crest 3D White; GIII - Colgate Total 12 Clean Mint; GIV - Colgate Optic White; GV - Placebo (negative control, fluoride-free dentifrice). The samples were submitted to daily erosive and abrasive challenges for 3 days. The erosive challenges were performed 3 times a day by immersing the specimens in 0.1% citric acid solution (pH 2.5) for 90 s. Each day after the first and last erosive challenges, the specimens were subjected to the abrasive challenge for 15 s, using a toothbrushing machine (Biopdi, São Carlos, SP, Brazil), soft toothbrushes and slurry (1:3 g/ml) of the tested toothpastes (1.5 N). The specimens were kept in artificial saliva between the challenges. The final profile was obtained and the ETW (µm) was calculated. Data were analyzed by Kruskal-Wallis and Dunn's tests (p<0.05). All dentifrices tested significantly reduced the enamel wear in comparison with the Placebo, except GIII. The median (95% CI) ETW was 1.35 (1.25-1.46)bc for GI, 1.17 (1.01-1.34)cd for GII, 1.36 (1.28-1.45)ab for GIII, 1.08 (1.04-1.14)d for GIV and 2.28 (2.18-2.39)a for GV. When dentifrices from the same manufacturer were compared, the whitening dentifrices led to similar or less wear than the regular ones.


  • The effect of fluoride on the structure, function, and proteome of a renal epithelial cell monolayer

    by Ligia S. Antonio, Pia Jeggle, Lesley J. MacVinish, James C. Bartram, Henry Miller, Gavin E. Jarvis, Flávia M. Levy, Mariana R. Santesso, Aline L. Leite, Rodrigo C. Oliveira, et al.

    High concentrations of fluoride in the body may cause toxic effects. Here, we investigated the effects of fluoride on the structure, function, and proteome of a cortical collecting duct epithelium in vitro. Kidney tubule cells (M‐1) were chosen because the concentration of fluoride in the kidney is 4–5‐fold higher than that in plasma. Mouse M‐1 cell monolayers were incubated in fluoride‐containing media, and the amiloride‐sensitive short‐circuit current and transepithelial resistance were measured. The Young's modulus of the epithelium was determined using atomic force microscopy, and the effect of fluoride on epithelial structure was assessed using scanning and transmission electron microscopy, and immunofluorescence. Differences in the expression of membrane proteins were evaluated using proteomics and bioinformatics. Fluoride exposure reduced both transepithelial Na+ transport and resistance. The IC50 for fluoride was ∼300 µM for both effects, and the half‐times for the decays of ion transport and resistance were 8.4 h and 3.6 days, respectively. Fluoride treatment did not affect the sensitivity of Na+ transport to amiloride. The Young's modulus of the epithelium was also unaffected by fluoride; however, the functional effects of fluoride were accompanied by marked structural effects. Proteomic analysis revealed changes in expression of a number of proteins, and particularly mitochondrial proteins. Treatment with fluoride had profound effects on the structure, function and proteome of a model cortical collecting duct epithelium. Significantly, however, these effects were produced only at concentrations considerably higher than those likely to be encountered in vivo. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 1455–1467, 2017.


  • Dentifrice pH but not consistency may affect fluoride uptake in plaque

    by C.A.B. Cardoso, F.M. Levy, C. Peres-Buzalaf, M.A.R. Buzalaf


  • Inhibition of tooth erosion by milk containing different fluoride concentrations: An in vitro study

    by A.C. Magalhães, F.M. Levy, B.M. Souza, C.A.B. Cardoso, L.P. Cassiano, J.P. Pessan, M.A.R. Buzalaf


  • Efficacy of TiF4 and NaF varnish and solution: a randomized in situ study on enamel erosive–abrasive wear

    by Flávia Mauad Levy, Daniela Rios, Marília A. R. Buzalaf, Ana Carolina Magalhães

    This in situ/ex vivo study analysed the anti-erosive/abrasive effect of TiF4 and NaF varnish and solution on enamel wear. Twelve subjects took part in this study which was performed in three periods (phases) with the duration of 5 days each. Each two human enamel specimens per subject were pretreated with experimental NaF varnish or solution (phase A), experimental-TiF4 varnish or solution (phase B) and placebo varnish or untreated control (phase C). The specimens were worn in palatal appliances; one enamel specimen, from each treatment, was subjected to erosion (ERO; cola soft drink, 4 × 90 s/day), and the other specimen was subjected to erosion plus abrasion (ERO + ABR; tooth brushing, 2 × 10 s/day). The tooth wear was quantified by a contact profilometer (micrometre) and analysed using two-way repeated measures ANOVA and Bonferroni’s test (n = 12 subjects, p < 0.05). All fluoride varnishes and solutions reduced the enamel wear (around 25 %) significantly compared to the control and placebo varnish. There were no significant differences among the fluoride formulations and between the conditions ERO and ERO + ABR. Therefore, it can be concluded that TiF4 has the same protective potential as NaF formulations to reduce human enamel wear under this experimental in situ model. In vitro studies have indicated a better anti-erosive/abrasive effect of TiF4 compared to NaF varnish. The present in situ study does not support the previous findings. Therefore, any of the tested professional fluoride varnishes in principle could be able to partially reduce enamel wear.


  • Total fluoride intake and excretion in children up to 4 years of age living in fluoridated and non‐fluoridated areas

    by F. V. Zohoori, M. A. R. Buzalaf, C. A. B. Cardoso, K. P. K. Olympio, F. M. Levy, L. T. Grizzo, D. F. B. Mangueira, F. C. Sampaio, A. Maguire

    Fractional fluoride retention is important during the early years of life when considering the risk of development of dental fluorosis. This study aimed to measure fractional fluoride retention in young children. The objectives were to investigate the relationships between fractional fluoride retention and total daily fluoride intake, age, and body mass index (BMI). Twenty‐nine healthy children, up to 4 yr of age, participated; 14 lived in a fluoridated area (0.64 μg ml−1 of fluoride in drinking water) and 15 lived in a non‐fluoridated area (0.04 μg ml−1 of fluoride in drinking water). The total daily fluoride intake of each child was calculated from the daily dietary fluoride intake and toothpaste ingestion (if fluoride toothpaste was used). Total daily fluoride excretion was measured by collecting voided urine and faeces over a 24‐h period, and fractional fluoride retention was calculated by dividing the amount of fluoride retained in the body (total daily fluoride intake minus total daily fluoride excretion) by the total daily fluoride intake. Nine children were excluded from data analysis because of suspected invalid samples. Mean (range) fractional fluoride retention for the remaining 20 children was 0.61 (0.06–0.98). There were no statistically significant correlations between fractional fluoride retention and either age or BMI. However, fractional fluoride retention was correlated with total daily fluoride intake: fractional fluoride retention = 1 − exp (−C × total daily fluoride intake), where C = 28.75 (95% CI = 19.75–37.75). The wide variation in fluoride retention in young children could have important implications when recommendations for fluoride use are being considered.